eCOA and EDC platform
The platform is for real-world and late-phase clinical studies.
Source: LinkedIn company description · Retrieved October 13, 2026
Climedo provides an eCOA and EDC platform for real-world and late-phase clinical studies.
Climedo was founded in Munich in 2017. The platform captures study data from its source with near-zero manual entry.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Climedo serves pharmaceutical, medical technology and contract research organizations, as well as academic institutions.
The platform is for real-world and late-phase clinical studies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 30, 2026, September 4, 2026, September 5, 2026, September 15, 2026, September 19, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 30, 2026, October 7, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.